SwedenBIOSwedenBIO appoints scientific relations ma... Maja Neiman is the first Science Relations Manager at SwedenBIO. The biotechnologist started her work at the end of March. more ➔
PhoreMostPhoreMost with new CEO Since the beginning of March, Dr Neil Torbett has been the new Chief Executive Officer of Cambridge-based PhoreMost Ltd. more ➔
Integra TherapeuticsIntegra Therapeutics strengthens Science A... Barcelona-based Integra Therapeutics appoints George Church to its Scientific Advisory Board. more ➔
InDex PharmaceuticalsCOO will leave InDex Pharmaceuticals InDex Pharmaceuticals needs a new COO. After ten years as Chief Operating Officer, Pernilla Sandwall will leave the Stockolm-based company at the end of April. more ➔
DiaccurateSolid financial experience for DiaccurateLaurence Riot Lamotte has started at the beginning of 2022 als new Chief Financial Officer of French Diaccurate. She succeeds José Da Gloria, who left the company. more ➔
New CEO for Galapagos Co-founder and former board member of Galapagos NV Dr Paul Stoffels will take over the position of Chief Executive Officer at the Belgian company from April. He succeeds long-time CEO Onno van de Stolpe, … more ➔
Immunovia with acting CEOImmunovia AB announces that Philipp Mathieu has been appointed as acting CEO and President with immediate effect. The search for a permanent CEO continues, as previously communicated. more ➔
Onxeo with interim CEO Paris-based Onxeo S.A. has started the new year with an interim CEO. Julien Miara has taken over the position. more ➔
Successor wanted Gabriella Björknert Caracciolo will leave Bactiguard AB, where she currently works as CFO and deputy CEO. more ➔
Back as CEO Swedish Oncopeptides has had a new CEO since mid-November. Jakob Lindberg has taken over the position from Marty J. Duvall again. He has left the company. more ➔